International Stem Cell (ISCO) EPS (Diluted) (QoQ) (2010 - 2025)
International Stem Cell (ISCO) EPS (Diluted) (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | International Stem Cell | 3.76 Mn | 2.67 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -814.25% |
| Sep 30, 2025 | 106.32% |
| Jun 30, 2025 | 51.87% |
| Mar 31, 2025 | -7,891.67% |
| Dec 31, 2024 | 109.60% |
| Sep 30, 2024 | -301.61% |
| Jun 30, 2024 | 123.48% |
| Mar 31, 2024 | 18.77% |
| Dec 31, 2023 | -148.09% |
| Sep 30, 2023 | -150.58% |
| Jun 30, 2023 | 861.73% |
| Mar 31, 2023 | -121.25% |
| Dec 31, 2022 | 146.65% |
| Sep 30, 2022 | -17,050.00% |
| Jun 30, 2022 | 77.78% |
| Mar 31, 2022 | 97.51% |
| Dec 31, 2021 | 61.40% |
| Sep 30, 2021 | -0.92% |
| Jun 30, 2021 | -9.42% |
| Mar 31, 2021 | -5.12% |